China's Biotech Boom at Crossroads After Gene Editing Trial Death The recent death of a young girl in a gene editing trial has sent shockwaves through China's burgeoning biotechnology sector.
The incident highlights the risks of unchecked enthusiasm for cutting edge technologies, where the promise of breakthroughs can lead to complacency.
The case involves a child who died days after receiving a bespoke gene editing therapy designed to correct a neurodevelopmental genetic mutation.